HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vascular integrin alpha(v)beta3: a new prognostic indicator in breast cancer.

Abstract
Blood vessel density is a prognostic indicator of multiple tumor types. Recently, it has been established that tumor-associated blood vessels express elevated levels of integrin alpha(v)beta3. In fact, there is evidence that integrin alpha(v)beta3 identifies the most proliferative endothelial cells within human breast carcinomas. Therefore, we evaluated breast cancer tissue in terms of both blood vessel density and alpha(v)beta3 expression. We found that the antibody LM609 to integrin alpha(v)beta3 preferentially stains the blood vessels of small caliber. Furthermore, comparative studies between LM609 and anti-CD31 antibodies on normal breast indicate that very low and weak expression of integrin alpha(v)beta3 was found on vessels within normal tissue, whereas CD31 antigen was expressed in almost all vasculature. Indeed, expression of integrin alpha(v)beta3 was significantly higher in tumors of patients with metastasis than in those without metastasis. In a series of 197 consecutive patients with invasive breast cancer and long follow-up, vascular expression of integrin alpha(v)beta3 in tumor vascular "hot spots" was found to be the most significant prognostic factor predictive of relapse-free survival in both node-negative and node-positive patients. These findings support the contention that angiogenesis plays a critical role in breast cancer progression and suggest that integrin alpha(v)beta3 is an endothelial cell marker with significant prognostic value and potential usefulness as a target for specific antiangiogenic therapy.
AuthorsG Gasparini, P C Brooks, E Biganzoli, P B Vermeulen, E Bonoldi, L Y Dirix, G Ranieri, R Miceli, D A Cheresh
JournalClinical cancer research : an official journal of the American Association for Cancer Research (Clin Cancer Res) Vol. 4 Issue 11 Pg. 2625-34 (Nov 1998) ISSN: 1078-0432 [Print] United States
PMID9829725 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antigens, Neoplasm
  • Integrins
  • Platelet Endothelial Cell Adhesion Molecule-1
  • integrin alphavbeta6
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Antigens, Neoplasm
  • Breast Neoplasms (blood supply, diagnosis, metabolism)
  • Cell Division
  • Cohort Studies
  • Endothelium, Vascular (metabolism, pathology)
  • Female
  • Humans
  • Integrins (biosynthesis)
  • Middle Aged
  • Neoplasm Invasiveness
  • Neoplasm Metastasis
  • Platelet Endothelial Cell Adhesion Molecule-1 (biosynthesis)
  • Prognosis
  • Survival Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: